Fresenius Medical Care AG (FMS) Operating Leases (2019 - 2026)

As of Dec 31, 2025, Fresenius Medical Care AG's Operating Leases came in at $3.27 billion, down 11.4% from the prior year.

• Annual Operating Leases has declined for four consecutive years, with a five-year compound annual growth rate of -5.3% (years ended Dec 2020 to Dec 2025).
• In prior years, Fresenius Medical Care AG's Operating Leases was $3.69 billion in the year ended Dec 31, 2024 (-0.2%), $3.7 billion in the year ended Dec 31, 2023 (-6.4%), $3.95 billion in the year ended Dec 31, 2022 (-16.3%) and $4.72 billion in the year ended Dec 31, 2021 (+9.9%).
• The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Operating Leases since the quarter ended Sep 30, 2020.
• On a year-over-year basis, Operating Leases has declined in each of the last 17 quarters, with an average decline of 5.2% over the last eight quarters.
• The strongest year-over-year quarter for Operating Leases in the past five years was the quarter ended Sep 30, 2021, with growth of 549.8%; the weakest was the quarter ended Jun 30, 2022, with a decline of 20.3%.
• According to Business Quant data, Operating Leases for the three prior quarters was $3.38 billion (quarter ended Mar 31, 2026), $3.37 billion (quarter ended Dec 31, 2025) and $3.44 billion (quarter ended Sep 30, 2025).